arrow_back Trending Legislation
Share share

End Tuberculosis Now Act: Global Health Action

This act aims to strengthen the United States' global efforts in combating tuberculosis. It focuses on improving diagnosis, treatment, and prevention of the disease worldwide, especially in high-burden countries. Citizens may experience indirect benefits through enhanced global health security and reduced risk of infectious disease spread.
Key points
Financial and technical support for global tuberculosis programs, including the development of new drugs and vaccines.
Strengthening healthcare systems in countries affected by tuberculosis to better detect and treat the disease.
Coordination with international organizations and partners for more effective combat against tuberculosis and future respiratory pandemics.
Regular reporting on progress and expenditures, increasing transparency and accountability in resource utilization.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
End Tuberculosis Now Act of 2022
Print number: S 3386
Sponsor: Sen. Menendez, Robert [D-NJ]
Process start date: 2021-12-14
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about End Tuberculosis Now Act: Global Health Action

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is S 3386.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-12-14.

What are the main provisions?

Key points include:

  • Financial and technical support for global tuberculosis programs, including the development of new drugs and vaccines.
  • Strengthening healthcare systems in countries affected by tuberculosis to better detect and treat the disease.
  • Coordination with international organizations and partners for more effective combat against tuberculosis and future respiratory pandemics.
  • Regular reporting on progress and expenditures, increasing transparency and accountability in resource utilization.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Menendez, Robert [D-NJ].

What is the latest detailed status?

The latest detailed status is: Placed on Senate Legislative Calendar under General Orders. Calendar No. 601.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

Analysis and Potential Impact of S 3386

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health